Make a gift before the end of the year to drive research breakthroughs in 2026. 
Search

NEWS

CONTACT US

DONATE

Europe Here 2022.Q2.rar
Europe Here 2022.Q2.rar

This is a podcast for neuroendocrine cancer patients and caregivers that presents expert information and patient perspectives.

Europe Here 2022.q2.rar Review

These map updates are primarily used for automotive navigation systems and mobile GPS applications that utilize HERE Technologies' data (formerly Navteq). Key Details

: Updates for built-in car navigation systems (e.g., Audi, BMW, Mercedes-Benz).

: This specific naming convention ( .rar file with Q-quarter designations) is frequently used in communities for iGO GPS software. Europe Here 2022.Q2.rar

: HERE Technologies, a major provider of mapping and location data. Release Date : These maps were released in mid-2022. Common Uses :

: The "HERE" sets often include specialized "FTR" files for truck-specific routing (weight limits, bridge heights). File Contents (Typical) These map updates are primarily used for automotive

If you extract this archive, you will likely find several subfolders: : Files ending in .fbl (the actual maps). poi : Points of Interest (gas stations, hotels). building : 3D landmarks and buildings ( .3dl , .3dc ). phoneme : Files for voice guidance pronunciation. speedcam : Speed camera alerts.

The file refers to a compressed archive containing HERE Maps data for Europe from the second quarter (Q2) of 2022 . : HERE Technologies, a major provider of mapping

: Since this data is from 2022 , it is now several years out of date. Newer versions (e.g., 2024 or 2025) are available through official automotive portals or navigation apps like the HERE WeGo app .

Subscribe to our podcast:

Sign up to have NETRF notify you of the next NETWise podcast. Or, find and subscribe to NETWise on your favorite podcast service. 

Apple
Spotify
RSS

Medical Disclaimer: This podcast is not intended as and shall not be relied upon as medical advice. The Neuroendocrine Tumor Research Foundation encourages all users to discuss any information found here with their oncologist, physician, and/or appropriate qualified health professional. Listening to this podcast does not constitute a patient-physician relationship. The Neuroendocrine Tumor Research Foundation does not represent that any information provided here should supplant the reasoned, informed advice of a patient’s oncologist, physician, or appropriate qualified health professional.